Your browser doesn't support javascript.
loading
Primary chemoablation of low-grade upper tract urothelial carcinoma using UGN-101, a mitomycin-containing reverse thermal gel (OLYMPUS): an open-label, single-arm, phase 3 trial.
Kleinmann, Nir; Matin, Surena F; Pierorazio, Phillip M; Gore, John L; Shabsigh, Ahmad; Hu, Brian; Chamie, Karim; Godoy, Guilherme; Hubosky, Scott; Rivera, Marcelino; O'Donnell, Michael; Quek, Marcus; Raman, Jay D; Knoedler, John J; Scherr, Douglas; Stern, Joshua; Weight, Christopher; Weizer, Alon; Woods, Michael; Kaimakliotis, Hristos; Smith, Angela B; Linehan, Jennifer; Coleman, Jonathan; Humphreys, Mitchell R; Pak, Raymond; Lifshitz, David; Verni, Michael; Adibi, Mehrad; Amin, Mahul B; Seltzer, Elyse; Klein, Ifat; Konorty, Marina; Strauss-Ayali, Dalit; Hakim, Gil; Schoenberg, Mark; Lerner, Seth P.
Afiliación
  • Kleinmann N; Department of Urology, Sheba Medical Center, Ramat Gan, Israel.
  • Matin SF; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Pierorazio PM; Brady Urological Institute, Johns Hopkins University, Baltimore, MD, USA.
  • Gore JL; Department of Urology, University of Washington Medical Center, Seattle, WA, USA.
  • Shabsigh A; Department of Urology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
  • Hu B; Department of Urology, Loma Linda University, Loma Linda, CA, USA.
  • Chamie K; Department of Urology, University of California Los Angeles, Los Angeles, CA, USA.
  • Godoy G; Department of Urology, Baylor College of Medicine, Houston, TX, USA.
  • Hubosky S; Department of Urology, Sidney Kimmel Medical College at Thomas Jefferson University Hospitals, Philadelphia, PA, USA.
  • Rivera M; Department of Urology, Mayo Clinic Health System, Rochester, MN, USA.
  • O'Donnell M; Department of Urology, University of Iowa, Iowa City, IA, USA.
  • Quek M; Department of Urology, Loyola University Medical Center, Maywood, IL, USA.
  • Raman JD; Division of Urology, Penn State Health Milton S Hershey Medical Center, Hershey, PA, USA.
  • Knoedler JJ; Division of Urology, Penn State Health Milton S Hershey Medical Center, Hershey, PA, USA.
  • Scherr D; Department of Urology, Weill Medical College of Cornell University, New York, NY, USA.
  • Stern J; Department of Urology, Albert Einstein College of Medicine, Bronx, NY, USA.
  • Weight C; Department of Urology, University of Minnesota Health, Minneapolis, MN, USA.
  • Weizer A; Department of Urology, University of Michigan, Ann Arbor, MI, USA.
  • Woods M; Department of Urology, Loyola University Medical Center, Maywood, IL, USA.
  • Kaimakliotis H; Department of Urology, Indiana University School of Medicine, Indianapolis, IN, USA.
  • Smith AB; Department of Urology, University of North Carolina School of Medicine, Chapel Hill, NC, USA.
  • Linehan J; Department of Urology, John Wayne Cancer Institute, Santa Monica, CA, USA.
  • Coleman J; Department of Urology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Humphreys MR; Department of Urology, Mayo Clinic Phoenix, Scottsdale, AZ, USA.
  • Pak R; Department of Urology, Mayo Clinic Jacksonville, Jacksonville, FL, USA.
  • Lifshitz D; Department of Urology, Rabin Medical Center, Tel Aviv, Israel.
  • Verni M; Urology Center of Las Vegas, Las Vegas, NV, USA.
  • Adibi M; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Amin MB; Department of Pathology, University of Tennessee Health Science Center, Memphis, TN, USA.
  • Seltzer E; UroGen Pharma, New York, NY, USA.
  • Klein I; UroGen Pharma, Ra'anana, Israel.
  • Konorty M; UroGen Pharma, Ra'anana, Israel.
  • Strauss-Ayali D; UroGen Pharma, Ra'anana, Israel.
  • Hakim G; UroGen Pharma, Ra'anana, Israel.
  • Schoenberg M; Department of Urology, Albert Einstein College of Medicine, Bronx, NY, USA; UroGen Pharma, New York, NY, USA.
  • Lerner SP; Department of Urology, Baylor College of Medicine, Houston, TX, USA. Electronic address: slerner@bcm.edu.
Lancet Oncol ; 21(6): 776-785, 2020 06.
Article en En | MEDLINE | ID: mdl-32631491
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Portadores de Fármacos / Carcinoma / Mitomicina / Urotelio / Neoplasias Renales / Antibióticos Antineoplásicos Tipo de estudio: Clinical_trials Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: America do norte / Asia Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Israel
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Portadores de Fármacos / Carcinoma / Mitomicina / Urotelio / Neoplasias Renales / Antibióticos Antineoplásicos Tipo de estudio: Clinical_trials Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: America do norte / Asia Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Israel